(Last updated : 2022-12-25 07:21:44)
  Yamasaki Keishi
   Department   SOJO UNIVERSITY  Department of Pharmaceutical Sciences, FACULTY OF PHARMACEUTICAL SCIENCES
■ Book and thesis
1. 2022 Article Structural basis of the change in the interaction between mycophenolic acid and subdomain IIA of human serum albumin during renal failure. J Med Chem doi: 10.1021/acs.jmedchem.2c01790 (Collaboration)  Link
2. 2022 Article Study of the Inclusion Complexes Formed Between 4-Phenylbutyrate and α-, β-, and γ-Cyclodextrin in Solution and Evaluation on Their Taste-Masking Properties. J Pharm Pharmacol doi: 10.1093/jpp/rgac090 (Collaboration)  Link
3. 2022 Article The Chlorine Atoms of Aripiprazole Molecule Control the Geometry and Motion of Aripiprazole and Deschloro-aripiprazole in the Subdomain IIIA of Human Serum Albumin. ACS Omega (Collaboration)  Link
4. 2022 Article An in vitro comparative study of the binding of caspofungin and micafungin to plasma proteins. J Pharm Pharmacol 74,pp.88-93 (Collaboration)  Link
5. 2022 Article Novel nitric oxide donor, nitrated phenylbutyrate, induces cell death of human pancreatic cancer cells and suppress tumor growth of cancer xenografts. Oncology Reports accepted (Collaboration)  Link
Display all(106)
■ Academic conference presentation
1. 2022 7-phenyl heptanoic acid ameliorates chronic kidney disease through the suppression of indoxyl sulfate production (第39回日本薬学会九州山口支部大会)
2. 2021/05 Investigation of the interaction between 4-phenylbutyric acid and cyclodextrins (日本薬剤学会第36年会)
3. 2015/11 Microenvironmental analysis of binding site of sodium phenylbutyrate on human serum albumin (Asian federation for pharmaceutical sciences (AFPS) 2015 conference)
4. 2015/11 The effects of liposomal hemoglobin-based artificial oxygen carriers (hemoglobin-vesicles) and red blood cells resuscitation on transfusion-related acute lung injury in hemorrhagic shock model rats (Asian federation for pharmaceutical sciences (AFPS) 2015 conference)
5. 2014/04/14 Study on protein binding of sodium phenylbutyrate (5th FIP Pharmaceutical Sciences World Congress)
Display all(9)
■ Academic background
1. 1986/04~1990/03 Faculty of Pharmaceutical Science, Kumamoto University, Graduated,
2. 1990/04~1992/03 〔Master Course〕, Kumamoto University, Completed,
3. 1992/04~1995/03 〔Doctorial Course〕, Graduate School, Division of Pharmaceutical Sciences, Kumamoto University, Completed,
■ Business career
1. 2014/04~ SOJO UNIVERSITY FACULTY OF PHARMACEUTICAL SCIENCES Department of Pharmaceutical Sciences
2. 2010/09~2011/03 The University of Sydney Advanced Drug Delivery Group Researcher
3. 2007/04~2014/03 SOJO UNIVERSITY FACULTY OF PHARMACEUTICAL SCIENCES Department of Pharmaceutical Sciences
4. 2001/04~2006/03 University of Miyazaki Hospital Department of Pharmacy Pharmacist
5. 1995/04~2001/03 Toray Industries, Inc. Pharmaceutical Research Laboratory Senior Researcher
Display all(7)
■ Home Page
   Laboratory of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Sojo University
■ Present specialized field
Biodiversity and systematics, Morphology and anatomical structure, Clinical pharmacy, Clinical pharmacy, Pharmaceutical analytical chemistry and physicochemistry 
■ Department laboratory expense researcher number
1.  :  Link